The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
Open accessAbstract
Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of conventional drug delivery, thereby reducing the amount of drug required for therapeutic efficacy. To achieve this objective, the magic bullet concept was developed and pushed scientists to investigate for more than a century, leading to the envisioning of different nanometer-sized devices - today's nanomedicine. Different carrier systems are being used and investigated, which include colloidal (vesicular and multiparticulate) carriers, polymers, and cellular/subcellular systems. This review addresses the need for and advantages of targeting, with its basic principles, strategies, and carrier systems. Recent advances, challenges, and future perspectives are also highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732
Targeted drug delivery strategies for precision medicines
Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,183
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Yoo, J., Park, C., Yi, G., Lee, D., & Koo, H. (2019) · Cancers · doi:10.3390/cancers11050640 · Cited by 726
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Bertrand, N., & Leroux, J.-C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.098 · Cited by 707
Preparation and characterization of liposomes as therapeutic delivery systems: a review
Vemuri, S., & Rhodes, C. T. (1995) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(95)00010-7 · Cited by 564
Lipid vesicles for skin delivery of drugs: Reviewing three decades of research
Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F., & Khalafallah, N. M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.005 · Cited by 537
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Valent, P., Groner, B., Schumacher, U., Superti-Furga, G., Busslinger, M., Kralovics, R., Zielinski, C., Penninger, J. M., Kerjaschki, D., Stingl, G., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000443526 · Cited by 409
Analysis on the current status of targeted drug delivery to tumors
Kwon, I. K., Lee, S. C., Han, B., & Park, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.010 · Cited by 404
Nanomedicine and drug delivery: a mini review
Mirza, A. Z., & Siddiqui, F. A. (2014) · International Nano Letters · doi:10.1007/s40089-014-0094-7 · Cited by 353
Design of Nanoparticle-Based Carriers for Targeted Drug Delivery
Yu, X., Trase, I., Ren, M., Duval, K., Guo, X., & Chen, Z. (2016) · Journal of Nanomaterials · doi:10.1155/2016/1087250 · Cited by 265
Recent Advances in Drug Delivery Systems
Martinho, N., Damgé, C., & Reis, C. P. (2011) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2011.225062 · Cited by 244
Fahmy, T. M., Fong, P. M., Goyal, A., & Saltzman, W. M. (2005) · Materials Today · doi:10.1016/s1369-7021(05)71033-6 · Cited by 192
Uskokovic, D., & Stevanovic, M. (2009) · Current Nanoscience · doi:10.2174/157341309787314566 · Cited by 182
Pharmacytes: An Ideal Vehicle for Targeted Drug Delivery
Freitas, R. A. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.413 · Cited by 155
Recent advances in drug delivery systems for enhancing drug penetration into tumors
He, B., Sui, X., Yu, B., Wang, S., Shen, Y., & Cong, H. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1831106 · Cited by 146
Mills, J. K., & Needham, D. (1999) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.9.11.1499 · Cited by 112
Abu‐Dahab, R., Schäfer, U. F., & Lehr, C. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00147-6 · Cited by 103
Novel advances in targeted drug delivery
Öztürk, K., Eroğlu, H., & Çalış, S. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1401076 · Cited by 103
Receptor-targeted Drug delivery: Current Perspective and Challenges
Vhora, I., Patil, S., Bhatt, P., Gandhi, R., Baradia, D., & Misra, A. R. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.63 · Cited by 93
Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue
Scott, R. C., Crabbe, D. L., Krynska, B., Ansari, R., & Kiani, M. F. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.459 · Cited by 80
Complexity and Simplification in the Development of Nanomedicines
Barz, M. (2015) · Nanomedicine · doi:10.2217/nnm.15.146 · Cited by 33
Macromolecules as targeted drugs delivery vehicles: an overview
Ali, Y., Alqudah, A. A., Ahmad, S. A., Hamid, S. A., & Farooq, U. (2019) · Designed Monomers & Polymers · doi:10.1080/15685551.2019.1591681 · Cited by 33
Dermal delivery of drugs using different vesicular carriers: A comparative review
Arora, S., Lamba, H., & Tiwari, R. K. (2012) · Asian Journal of Pharmaceutics · doi:10.4103/0973-8398.107558 · Cited by 13
Cited by
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Sharma, S., Bhattacharya, S., Joshi, K., & Singh, S. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05331-8 · Cited by 13
Metadata
- Authors
- Tewabe, A., Abate, A., Tamrie, M., Seyfu, A., & Abdela Siraj, E.
- Venue
- Journal of Multidisciplinary Healthcare
- Publisher
- Informa UK Limited
- Published
- 2021-07
- Volume
- Volume 14
- Pages
- 1711-1724
- ISSN
- 1178-2390 (ISSN-L)
- OpenAlex
- W3180441560
- Cited by
- 375
- References
- 28
- FWCI
- 12.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.